Test Price
2,800 AED✅ Home Collection Available
NIPA1 Gene (SPG6) Next-Generation Sequencing (NGS) DNA Test in Dubai, UAE
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy. Available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NIPA1 gene (SPG6) NGS test screens for hereditary spastic paraplegia type 6 using next-generation sequencing of the entire coding region. This advanced genetic analysis confirms pathogenic mutations in the NIPA1 gene associated with autosomal dominant hereditary spastic paraplegia.
| Feature | Our Test (NGS, ISO-Certified) | Closest Alternative (Sanger-Based Panel) |
|---|---|---|
| Precision | Full-gene NGS with >99% analytical sensitivity | Limited to targeted exons, ~85% sensitivity |
| Method | Next-Generation Sequencing (Illumina® platform) | Sanger sequencing of selected variants |
| Turnaround | 3 – 4 weeks | 6 – 8 weeks (often sent abroad) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403 advises: “This NGS-based test provides definitive molecular confirmation for Hereditary Spastic Paraplegia Type 6 (SPG6). It is crucial to understand that a negative result does not fully exclude a genetic etiology. Comprehensive clinical correlation, including neurological evaluation and family history analysis, is essential. I strongly recommend consulting with a certified genetic counselor to integrate these findings into your personalized management strategy.”
Clinical Advisory
Do not alter prescribed therapies without specialist consultation.
Medications such as baclofen or tizanidine should not be adjusted based solely on this genetic result. All therapeutic decisions must be guided by a neurologist.
Exclusion Criteria & Emergency Indicators
- Refrain from booking if you are currently hospitalised for an acute neurological event.
- If you experience sudden severe muscle weakness, loss of bowel/bladder control, or respiratory difficulty, seek emergency care immediately.
- Testing for minors requires explicit guardian consent governed under Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the NIPA1 SPG6 NGS test detect and how is it collected?
The test identifies pathogenic variants in the NIPA1 gene linked to autosomal dominant hereditary spastic paraplegia type 6. A standard blood draw is performed by our mobile phlebotomist between 8 AM and 11 PM, or you may visit our DHCC laboratory.
2. Why choose this UAE-based NGS test over sending samples abroad?
Local ISO-certified processing ensures a faster 3-4 week turnaround with full DHA compliance. Your genetic data remains protected under UAE PDPL. You avoid international shipping delays and have direct access to local specialists for result interpretation.
3. Is the NIPA1 test covered by insurance and what pre-steps are required?
We assist with direct billing verification through most UAE insurers. A mandatory pre-test genetic counseling session is required. Please bring any previous neurological reports and family history documents.
UAE Regulatory & Data Privacy Adherence
Commitment to UAE Law:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Your genetic data is processed, stored, and transmitted in strict compliance with the UAE's federal data protection framework.
- Federal Law No. 2 of 2019: All health information communication and telemedicine practices adhere to this governing law.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical safety protocols and informed consent processes are fully aligned with this decree.
Clinical & Logistical Metadata
| Test Name | NIPA1 Gene (SPG6) Next-Generation Sequencing (NGS) DNA Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (Illumina® Platform) |
| ICD-10-CM Code | G11.4 |
| LOINC Code | 94231-5 |
| DHA Facility License & Laboratory Address | License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians